SNES
SenesTechFAI scenario view
RankAlpha Sentiment CodexThe current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
Company news is constructive on distribution, but the September 23 Grove announcement contains no sales commitment. The packet does not establish a post-release price reaction, consensus earnings surprise, analyst revisions, reliable target coverage, or sufficient social, options, short-interest or employee-review data; the zero sentiment-field values denote unavailable data, not neutral measurements. The deterministic directional prior is neutral, supporting a low-conviction monitoring stance.
Evidence flagged
small-cap biotech peer set is too weak or includes unrelated comparators for a standard-conviction report
AI events
SenesTech said Evolve products would soon be available on Grove Collaborative's marketplace, but disclosed no launch date, order commitment or sales forecast. Actual availability and measurable incremental sales remain unproven [#PR-2026-09-23] (company release). The date is a monitoring horizon.
SenesTech reported Q2 revenue of $770,000, up 23% year over year, e-commerce revenue of $511,000 and a 73.6% gross margin. July e-commerce revenue rose 19% from June. Sustained sales and margin performance—not the single-quarter acceleration—is the test. The results release was furnished with the August 5 8-K [#8-K-2026-08-05] [#SEC-8K-2026-08-05]; figures come from its Exhibit 99.1. The date is a monitoring horizon, not an announced reporting date.
The June 30 10-Q reported $5.08 million in cash and $3.64 million of operating cash use in the first half. Management expected existing cash plus anticipated revenue to fund operations through Q1 2027 and said additional financing would be needed before profitability [#10-Q-2026-08-06] (SEC filing). Financing terms or a change in cash use could materially alter per-share value.
Recommendation
No formal recommendation provided.

